These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 52180)

  • 1. Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood.
    MacDonald HR; Bonnard GD; Sordat B; Zawodnik SA
    Scand J Immunol; 1975 Sep; 4(5-6):487-97. PubMed ID: 52180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effector cells involved in cell-mediated lympholysis and antibody-dependent cell-mediated cytotoxicity in man.
    MacDonald HR; Bonnard GD
    Scand J Immunol; 1975; 4(2):129-38. PubMed ID: 124942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.
    Greenberg AH; Shen L; Medley G
    Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erthrocyte and herpesvirus-infected bovine target cells.
    Rouse BT; Wardley RC; Babiuk LA
    Infect Immun; 1976 May; 13(5):1433-41. PubMed ID: 1270149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
    Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
    J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent cell-mediated destruction of human erythrocytes sensitized in ABO and rhesus fetal-maternal incompatibilities.
    Zawodnik SA; Bonnard GD; Gautier AE; Macdonald HR
    Pediatr Res; 1976 Sep; 10(9):791-6. PubMed ID: 822389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent human lymphocytotoxicity: a micro assay system.
    Zeijlemaker WP; Roos MT; Schellekens PT; Eijsvoogel VP
    Eur J Immunol; 1975 Aug; 5(8):579-84. PubMed ID: 824141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell.
    Trinchieri G; Bauman P; De Marchi M; Tökés Z
    J Immunol; 1975 Jul; 115(1):249-55. PubMed ID: 125298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
    Dennert G; Hatlen LE
    J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis of alloantibody-sensitized human erythrocytes by peripheral blood mononuclear cells: heterogeneity of effector populations.
    Kimber I; Moore M
    J Clin Lab Immunol; 1981 Jan; 5(1):41-6. PubMed ID: 6260947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
    Brier AM; Chess L; Schlossman SF
    J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes.
    Katz P; Simone CB; Henkart PA; Fauci AS
    J Clin Invest; 1980 Jan; 65(1):55-63. PubMed ID: 6243141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cell-mediated cytotoxicity in human cancer: characterization of patient leukocyte activity and treatment effects.
    Hersh EV; Murphy SG; Gutterman JU; Morgan J; Quesada J; Zander A; Stewart D
    Cancer; 1982 Jan; 49(2):251-60. PubMed ID: 7032682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface receptors and immune activity of purified human circulating mononuclear cells. III. The mechanisms of lysis, by lymphocytes and monocytes, of target cells in the lymphocyte-dependent and monocyte-dependent ADCC, NK, NOCC, and MICC cytotoxic reactions.
    Richter M; Kazaniwsky N
    Cell Immunol; 1987 Sep; 108(2):297-312. PubMed ID: 3621351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent cell-mediated cytotoxicity. Comparative ability of murine Peyer's patch and spleen cells to lyse lipopolysaccharide-coated and uncoated erythrocytes.
    Kagnoff MF; Campbell S
    Gastroenterology; 1976 Mar; 70(3):341-6. PubMed ID: 1082425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cytolytically active human leukocytes: an analysis of inactivation following in vitro interaction with antibody-coated target cells.
    Ziegler HK; Henney CS
    J Immunol; 1975 Dec; 115(6):1500-4. PubMed ID: 1184963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse effector functions involved in the antibody-dependent cellular cytotoxicity to xenogeneic erythrocytes.
    Cohen SA; Ehrke MJ; Mihich E
    J Immunol; 1975 Oct; 115(4):1007-12. PubMed ID: 1100718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte-dependent antibody in sheep immunized with murine mastocytoma cells.
    Grant CK; Adams E; Miller HR
    Eur J Immunol; 1975 May; 5(5):324-30. PubMed ID: 824135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
    Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
    J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytotoxic effector potential of some common non-lymphoid tumors and cultured cell lines with phytohemagglutinin and heterologous anti-erythrocyte antisera.
    Muchmore AV; Nelson DL; Blaese RM
    J Immunol; 1975 Mar; 114(3):1001-3. PubMed ID: 803533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.